Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8)

Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) 是一种 TGF-β IgG 抗体抑制剂,可减轻单侧输尿管梗阻 (UUO) 模型小鼠的肾纤维化,并在胰腺癌等多种肿瘤模型中显示出强大的抗肿瘤作用。
Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8)
产品编号: MS-C34100 纯度: 97.44% 分子量: 150 kDa
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
50mg
询价
询价
100mg
询价
询价
(100μg)
询价
询价
(100µg)
询价
询价

产品描述

Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) 是一种 TGF-β IgG 抗体抑制剂,可减轻单侧输尿管梗阻 (UUO) 模型小鼠的肾纤维化,并在胰腺癌等多种肿瘤模型中显示出强大的抗肿瘤作用。

生物实验数据

生物活性 Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) is a TGF-β IgG antibody inhibitor that alleviates renal fibrosis in mice with unilateral ureteral obstruction (UUO) and exhibits potent antitumor effects in various tumor models, such as pancreatic cancer.
IC50 & Target

TGF-β

体内研究
(In Vivo)

Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) (500 μg,静脉注射,移植前一天给药和移植后 5 周内每周给药 3 次) 可强烈抑制接种 TC-1 细胞的模型小鼠中的肿瘤生长。
Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) (25 μg/mouse,瘤内注射,在第 4、7、11、14 天给药) 与 PD-1 联合使用可抑制 B16F10E 基因敲除肿瘤小鼠模型中的肿瘤生长。
Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) (1-10 mg/kg,腹腔注射,每天 1 次,连续 5 天) 可减轻单侧输尿管梗阻 (UUO) 模型小鼠的肾纤维化。
Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) (200 μg,每周两次,持续 21 天) 可显著改善晚期胰腺癌小鼠的总体死亡率、体重减轻、脂肪量、瘦体重、骨密度和骨骼肌蛋白水解。

Animal Model: Mice were grafted with 5 x 105 TC-1 cells (C57BL/6, female, 5-6 weeks)
Dosage: 500 μg
Administration: Intravenously injection, one day before graftion and three times a week for 5 weeks after graftion
Result: Strongly reduced the TC-1 tumor growth.
Animal Model: B16F10E-knockout tumor mice models (C57BL/6, female, 7-9 weeks)
Dosage: 25 μg/mouse
Administration: Intra-tumourally injection, at days 4, 7, 11, 14 with 200 μg/mouse of anti-PD-1
Result: Suppressed tumor growth and decreased CD8+ cells.
Animal Model: Unilateral ureteral obstruction (UUO) mice models (CD1, male, 25-30 g)
Dosage: 1, 3, and 10 mg/kg
Administration: Intraperitoneally injection, daily for 5 days
Result: Decreased the elevated levels of Col1a1.
Induced a dose-related reduction in the binding of the FnEDA mAb.
Decreased collagen.
Animal Model: Endogenous models of advanced murine pancreatic cancer (C57BL/6, female, 6-8 weeks)
Dosage: 200 μg
Administration: Twice weekly for 21 days
Result: Exhibited lower serum levels of TGF-β and lower levels of TGF-β and downstream signaling marker p-SMAD2/3 in skeletal muscle.
Improved survival and significantly less weight loss.
Had higher fat mass, skinfold thickness, and bone mineral density.
Significantly decreased proteolysis.
Effectively attenuated pancreatic cancer cachexia with higher rotarod running speed.
性状 液体
颜色 Colorless to light yellow

化学信息

分子量 150 kDa

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础